About Velox Biologics
Velox Biologics is a Healthcare company based in Chandigarh (India) founded in 2011. Velox Biologics manufactures and markets pharmaceutical drugs and offers franchise services. It operates on a B2B model. Its Indian entity Velox Biologics Private Limited reported revenue of ₹1.77 Cr. Velox Biologics offers products and services including Loxyp-T, Pantalox 40, Loxitra 200, and Injectables. Its focus areas include Pharmaceuticals, Herbal Medicines, Drug Manufacturing and Formulations.
Company details
Velox Biologics , Based In Chandigarh, India, Produces A Wide Range Of Pharmaceutical Formulations Including Tablets, Capsules, And Injections. They Focus On Quality Assurance With Iso Certification And Whogmp Standards. The Company Markets These Products Through Ethical Pcd Pharma Franchise Models, Distributing To Associates Across India For Improved Healthcare Access. They Cater To Various Categories Like Antibiotics And Antacids, Emphasizing Safe And Effective Medicines.
- Headquarters Chandigarh, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website veloxbiologics.com
- Social LinkedIn X Facebook Instagram
- Legal Name Velox Biologics Private Limited
- Date of Incorporation 04 Feb, 2011
- Jurisdiction Chandigarh, India
- Annual Revenue₹1.77 Cr
FY 2025 · +12% YoY
- Net Profit₹1.5 Lakh
FY 2025 · 1% margin
- EBITDA₹7.2 Lakh
FY 2025 · 4% margin
Associated legal entities of Velox Biologics
Velox Biologics operates through Velox Biologics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Velox Biologics Private Limited CIN U24232CH2011PTC032721 | Active | 04 Feb 2011 | Chandigarh, Chandigarh | ₹1.8 Cr | 2 | View details |
Products & Services of Velox Biologics
Velox Biologics offers a comprehensive portfolio of products and services, including Loxyp-T, Pantalox 40, Loxitra 200, and Injectables.
Tablet for treating acid-related digestive issues effectively.
Medication for gastric problems and relief from acidity.
Antibiotic tablet for bacterial infections and health support.
Injections for various treatments and medical conditions.
Board of directors of Velox Biologics Private Limited (Velox Biologics)
Velox Biologics Private Limited is the primary company behind Velox Biologics. The board of Velox Biologics Private Limited currently have 2 directors; the longest-serving is Sumesh Kumar Sharma, appointed in 2011. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sumesh Kumar Sharma DIN 02959611 | Director | 04 Feb 2011 | 15 yrs 9 mo | Velox Biologics Private Limited |
| Ashish Sharma DIN 09012860 | Director | 28 Jan 2021 | 5 yrs 9 mo | Velox Biologics Private Limited |
Financials of Velox Biologics
Figures of Velox Biologics Private Limited, the primary company behind Velox Biologics, for FY 2025. Revenue was ₹1.77 Cr (+12% year on year). Net profit was ₹1.5 Lakh (1% margin). EBITDA was ₹7.2 Lakh (4% margin). Revenue has grown at a compounded annual rate of +9% over three years and +2% over five years.
- ₹1.77 CrRevenue · FY 2025 · +12% YoY
- ₹1.5 LakhNet profit · 1% margin
- ₹7.2 LakhEBITDA · 4% margin
- ₹2 LakhPaid-up capital
- +9%Revenue CAGR, 3 years
- +2%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Velox Biologics Private Limited are on its company page.
Detailed financial statements for Velox Biologics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Velox Biologics
The website of Velox Biologics (veloxbiologics.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▲ 734.8% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Velox Biologics
Velox Biologics was founded in 2011.
Velox Biologics is headquartered in Chandigarh, India.
The primary company behind Velox Biologics, Velox Biologics Private Limited, reported revenue of ₹1.77 Cr for FY 2025, up 12% year on year.
Velox Biologics , Based In Chandigarh, India, Produces A Wide Range Of Pharmaceutical Formulations Including Tablets, Capsules, And Injections. They Focus On Quality Assurance With Iso Certification And Whogmp Standards. The Company Markets These Products Through Ethical Pcd Pharma Franchise Models, Distributing To Associates Across India For Improved Healthcare Access. They Cater To Various Categories Like Antibiotics And Antacids, Emphasizing Safe And Effective Medicines.
Velox Biologics offers Loxyp-T, Pantalox 40, Loxitra 200, and Injectables.
Velox Biologics operates through Velox Biologics Private Limited.
The legal entities of Velox Biologics currently have 2 directors, including Sumesh Kumar Sharma, Ashish Sharma.